UBS Group
CVRX icon

UBS Group’s CVRx CVRX Stock Holding History

UBS Group’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
224,233
+120,423
+116% +$777K ﹤0.01% 5603
2026
Q1 		$982K Buy
103,810
+15,409
+17% +$113K ﹤0.01% 5571
2025
Q4 		$628K Sell
88,401
-62,922
-42% -$574K ﹤0.01% 5945
2025
Q3 		$1.22M Buy
151,323
+63,179
+72% +$475K ﹤0.01% 5391
2025
Q2 		$518K Buy
88,144
+13,846
+19% +$95.5K ﹤0.01% 5975
2025
Q1 		$909K Buy
74,298
+387
+0.5% +$5.47K ﹤0.01% 5367
2024
Q4 		$936K Buy
73,911
+48,752
+194% +$601K ﹤0.01% 5351
2024
Q3 		$222K Buy
25,159
+5,771
+30% +$52.5K ﹤0.01% 5792
2024
Q2 		$232K Buy
19,388
+7,893
+69% +$90.9K ﹤0.01% 5562
2024
Q1 		$209K Sell
11,495
-913
-7% -$21.6K ﹤0.01% 5826
2023
Q4 		$390K Buy
12,408
+6,152
+98% +$115K ﹤0.01% 5301
2023
Q3 		$94.9K Sell
6,256
-910
-13% -$15K ﹤0.01% 5863
2023
Q2 		$111K Buy
7,166
+6,566
+1,094% +$80.1K ﹤0.01% 5922
2023
Q1 		$5.59K Hold
600
– – ﹤0.01% 8016
2022
Q4 		$11K Hold
600
– – ﹤0.01% 8446
2022
Q3 		$6K Sell
600
-5,319
-90% -$42.1K ﹤0.01% 9014
2022
Q2 		$36K Buy
5,919
+125
+2% +$719 ﹤0.01% 6184
2022
Q1 		$35K Sell
5,794
-4,364
-43% -$35.2K ﹤0.01% 6839
2021
Q4 		$125K Buy
10,158
+1,558
+18% +$22.6K ﹤0.01% 6099
2021
Q3 		$142K Buy
8,600
+7,741
+901% +$148K ﹤0.01% 5576
2021
Q2 		$24K Buy
+859
New +$24.1K ﹤0.01% 7134

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group's CVRX Position: Q2 2026 in Review

UBS Group increased its CVRx (CVRX) stake by 116% in Q2 2026, buying an estimated $777K and bringing the position to 224,233 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #5603.

UBS Group first reported a position in CVRX in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.22M in Q3 2025. 87 funds tracked by Wall St. Rank hold CVRX as of Q2 2026.

  • UBS Group held 224,233 shares of CVRx worth $1.15M as of Q2 2026.
  • UBS Group bought 120,423 CVRx shares in Q2 2026, an estimated $777K.
  • CVRx made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5603 holding.
  • UBS Group first reported a position in CVRx in Q2 2021 and has held it in 21 quarters since.
  • UBS Group's CVRx position peaked at $1.22M in Q3 2025.
  • 87 funds tracked by Wall St. Rank held CVRx as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.